Anxiety, Depression, and Apathy as Predictors of Cognitive Decline in Patients With Parkinson's Disease-A Three-Year Follow-Up Study.

Parkinson's disease anxiety mild cognitive impairment neuropsychiatry neuropsychology

Journal

Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899

Informations de publication

Date de publication:
2022
Historique:
received: 11 10 2021
accepted: 10 01 2022
entrez: 25 2 2022
pubmed: 26 2 2022
medline: 26 2 2022
Statut: epublish

Résumé

Anxiety, depression, and apathy are the most common neuropsychiatric symptoms in Parkinson's disease (PD) patients. They impair cognitive functioning and have a profound impact on quality of life. This follow-up study aims to investigate the predictive value of anxiety, depression, and apathy on the development of Mild Cognitive Impairment (MCI) in PD patients. Twenty-nine cognitively unimpaired PD patients (mean age 68.2 SD ± 7.12 years; 13 women) participated in this study. At Baseline (BL) levels of apathy (Apathy Evaluation Scale, AES), depression (Beck Depression Inventory, BDI-II), and anxiety (Beck Anxiety Inventory, BAI), were assessed. Cognitive status was reassessed three years later according to MCI/non-MCI status. For statistics, we used binary logistic regression and receiver operating characteristic curve (ROC) analysis to examine anxiety, apathy, and depression at BL as a predictor of MCI status three years later. Eight of the 29 patients developed MCI. Anxiety level at BL was found to predict MCI status at three-year follow-up ( This study shows an association between anxiety and the development of MCI in PD patients, although the association between apathy, depression, and MCI did not reach a significant level.

Identifiants

pubmed: 35211081
doi: 10.3389/fneur.2022.792830
pmc: PMC8860828
doi:

Types de publication

Journal Article

Langues

eng

Pagination

792830

Informations de copyright

Copyright © 2022 Toloraia, Meyer, Beltrani, Fuhr, Lieb and Gschwandtner.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Front Psychol. 2017 Jan 04;7:1975
pubmed: 28101066
J Neuropsychiatry Clin Neurosci. 2016 Summer;28(3):211-6
pubmed: 26792098
Am J Geriatr Psychiatry. 2017 Mar;25(3):279-289
pubmed: 27838315
Neuropsychologia. 2018 Sep;118(Pt B):4-11
pubmed: 29787739
Mov Disord Clin Pract. 2021 Feb 18;8(3):390-399
pubmed: 33816668
J Neurol. 2014 Dec;261(12):2319-28
pubmed: 25228003
Mov Disord. 2014 Jul;29(8):1035-43
pubmed: 24862344
J Neuropsychiatry Clin Neurosci. 2015 Summer;27(3):213-8
pubmed: 25162776
Parkinsonism Relat Disord. 2017 Mar;36:63-68
pubmed: 28108263
Neuropsychiatr Dis Treat. 2017 Mar 16;13:815-826
pubmed: 28352181
Int J Geriatr Psychiatry. 2009 Mar;24(3):300-5
pubmed: 18759379
Arch Gen Psychiatry. 1961 Jun;4:561-71
pubmed: 13688369
Neurol Res Int. 2016;2016:6254092
pubmed: 27800180
Mov Disord. 2010 Nov 15;25(15):2649-53
pubmed: 21069833
Prog Brain Res. 2010;184:325-41
pubmed: 20887883
Fortschr Neurol Psychiatr. 2006 Dec;74(12):714-22
pubmed: 17167730
Mov Disord. 2011 Feb 15;26(3):407-15
pubmed: 21384425
Mov Disord. 2003 Jul;18(7):738-50
pubmed: 12815652
J Neurol Neurosurg Psychiatry. 1988 Jun;51(6):745-52
pubmed: 2841426
Parkinsonism Relat Disord. 2011 Dec;17(10):717-23
pubmed: 21741874
Mov Disord Clin Pract. 2021 Apr 04;8(4):571-581
pubmed: 33981790
J Consult Clin Psychol. 1988 Dec;56(6):893-7
pubmed: 3204199
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
Neurology. 2014 Apr 8;82(14):1219-26
pubmed: 24623840
Mov Disord. 2010 May 15;25(7):838-45
pubmed: 20461800
Neuropsychology. 2019 Nov;33(8):1111-1120
pubmed: 31343240
Parkinsons Dis. 2012;2012:308097
pubmed: 22970412
Minerva Med. 2011 Dec;102(6):441-59
pubmed: 22193376
Neuropsychology. 2017 Sep;31(6):596-604
pubmed: 28425730
Korean J Anesthesiol. 2019 Dec;72(6):558-569
pubmed: 31304696
Mov Disord. 2000 Nov;15(6):1221-4
pubmed: 11104209
Acta Neurol Scand Suppl. 2003;179:25-8
pubmed: 12603247
Mov Disord. 2012 Mar;27(3):349-56
pubmed: 22275317
Int J Geriatr Psychiatry. 2020 Apr;35(4):396-404
pubmed: 31894601

Auteurs

Ketevan Toloraia (K)

Department of Neurology, University Hospital Basel, Basel, Switzerland.

Antonia Meyer (A)

Department of Neurology, University Hospital Basel, Basel, Switzerland.

Selina Beltrani (S)

Department of Neurology, University Hospital Basel, Basel, Switzerland.

Peter Fuhr (P)

Department of Neurology, University Hospital Basel, Basel, Switzerland.

Roselind Lieb (R)

Division of Clinical Psychology and Epidemiology, Department of Psychology, University of Basel, Basel, Switzerland.

Ute Gschwandtner (U)

Department of Neurology, University Hospital Basel, Basel, Switzerland.

Classifications MeSH